Correvio Pharma (CORV) Tops Q4 EPS by 3c, Revenues Beat

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/14/2026

1. DPZ
2. NVDA
3. AVAV
4. BAC
5. UNH
6. ORCL
7. GS
8. DVLT
9. LQDA
10. ACI

Go back to Correvio Pharma (CORV) Tops Q4 EPS by 3c, Revenues Beat

Correvio Pharma (CORV) Reports at the Market Offering Up to $50M

March 14, 2019 7:23 AM EDT

Correvio Pharma Corp. (NASDAQ: CORV) today announced that it has entered into an At the Market Sales Issuance Agreement dated March 13, 2019 (the "Sales Agreement") with Cantor Fitzgerald & Co. ("Cantor") as agent, pursuant to which the Company may, from time to time sell, through "at-the-market" offerings on the Nasdaq Capital Market or another existing trading market in the United States with... More